P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL

ABSTRACT:

SUBMITTER: Maria Ribera J 

PROVIDER: S-EPMC10431106 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature